i was kinda focussing on the hfref surrogate. they released this a while back suggesting/hoping it may be considered an appropriate endpoint.
with the encouraging feedback from meeting it sounds like they may get their wish. i wonder how much big pharma would have to take notice.
well they have a cartoon for proposed moa so must be fairly well described
Ann: Half Year Financial Results Presentation, page-76
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.050(4.44%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.07 | $7.139M | 6.481M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 69064 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 74211 | 21 |
View Market Depth
| Last trade - 15.34pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |